Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015.

JNCI Cancer Spectrum
Alexandra ThomasPaul A Romitti

Abstract

Although recent findings suggest that de novo stage IV breast cancer is increasing in premenopausal women in the United States, contemporary incidence and survival data are lacking for stage I-III cancer. Women aged 20-29 (n = 3826), 30-39 (n = 34 585), and 40-49 (n = 126 552) years who were diagnosed with stage I-III breast cancer from 2000 to 2015 were identified from the Surveillance, Epidemiology, and End Results 18 registries database. Age-adjusted, average annual percentage changes in incidence and 5- and 10-year Kaplan-Meier survival curves were estimated by race and ethnicity, stage, and hormone receptor (HR) status and grade (low to well and moderately differentiated; high to poorly and undifferentiated) for each age decade. The average annual percentage change in incidence was positive for each age decade and was highest among women aged 20-29 years. Increased incidence was driven largely by HR+ cancer, particularly HR+ low-grade cancer in women aged 20-29 and 40-49 years. By 2015, incidence of HR+ low- and high-grade cancer each independently exceeded incidence of HR- cancer in each age decade. Survival for HR+ low- and high-grade cancer decreased with decreasing age; survival for HR- cancer was similar across age de...Continue Reading

References

Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Eva SingletaryFrederick L Greene
May 5, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M VanhuyseJ Bonneterre
May 30, 2007·British Journal of Cancer·C BouchardyE Rapiti
Oct 29, 2009·Journal of the National Cancer Institute·Marina PollánCarmen Martínez
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Elizabeth H HammondAntonio C Wolff
Dec 1, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carey K AndersCharles M Perou
Feb 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A GanzSandra M Swain
Oct 19, 2011·Annals of Internal Medicine·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Nov 15, 2011·Breast Cancer Research and Treatment·L C CollinsA H Partridge
Jan 21, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hatem A AzimSherene Loi
Mar 30, 2012·Breast Cancer Research and Treatment·D F MerloUNKNOWN AIRTUM WG
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laetitia HuiartRoch Giorgi
Sep 6, 2012·Breast Cancer Research and Treatment·Rachel A FreedmanNancy L Keating
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Rebecca H JohnsonArchie Bleyer
Jun 1, 2013·Journal of the National Cancer Institute·Ellen CopsonUNKNOWN POSH Study Steering Group
Jun 19, 2013·Cancer Epidemiology·Brice LeclèreUNKNOWN GRELL Working Group
Nov 8, 2013·Journal of General Internal Medicine·Sarah W PrimeauTracy A Battaglia
Dec 19, 2013·Cancer·Kathryn J RuddyAnn H Partridge
Mar 13, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Aliasghar KeramatiniaAlireza Mosavi-Jarrahi
May 20, 2014·Breast Cancer Research and Treatment·Dharanija MadhavanBarbara Burwinkel
Jun 3, 2014·The New England Journal of Medicine·Olivia PaganiUNKNOWN International Breast Cancer Study Group
Dec 2, 2014·Breast Cancer Research : BCR·Hatem A Azim, Ann H Partridge
Dec 17, 2014·The New England Journal of Medicine·Prudence A FrancisUNKNOWN International Breast Cancer Study Group
Feb 11, 2015·The Breast : Official Journal of the European Society of Mastology·Olivia PaganiAnn H Partridge
Aug 27, 2015·Journal of the National Cancer Institute·Natalia C LlarenaJacqueline S Jeruss
Feb 13, 2016·JAMA Oncology·Shoshana M RosenbergAnn H Partridge
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs
Aug 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeRulla M Tamimi
Sep 30, 2016·Breast Cancer Research and Treatment·Emily K Hartman, Guy D Eslick
Nov 30, 2016·Clinical Epigenetics·Qiuqiong TangBarbara Burwinkel
Dec 21, 2016·Breast Cancer Research : BCR·Natsue UehiroMasakazu Toi
Apr 20, 2017·JAMA Surgery·Olivia M ValenciaHassan Aziz
Jul 21, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jie SunYuntao Xie
Sep 16, 2017·Scientific Reports·Weibin LianChuan Wang
Oct 4, 2017·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Dec 17, 2017·Breast Cancer Research and Treatment·Alexandra S ZimmerStanley Lipkowitz
Jun 5, 2018·The New England Journal of Medicine·Prudence A FrancisUNKNOWN SOFT and TEXT Investigators and the International Breast Cancer Study Group
Jun 8, 2018·Journal of the National Cancer Institute·Matteo LambertiniEvandro de Azambuja

❮ Previous
Next ❯

Citations

Jul 11, 2020·Clinical Medicine Insights. Oncology·Francesca ParisiMatteo Lambertini
Nov 3, 2020·Breast Cancer Research and Treatment·Xueying HuEmily B Ambinder
Nov 5, 2020·Breast Cancer Research and Treatment·Victoria Sopik
Apr 4, 2021·International Journal of Molecular Sciences·Braden MillerLacey R McNally
Nov 5, 2021·Nature Communications·Sonali JindalPepper Schedin

❮ Previous
Next ❯

Software Mentioned

Stat
Joinpoint Regression
SEER
R
Joinpoint

Related Concepts

Related Feeds

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.